Adults 50 to 75, any sex, with Stroke or Stroke, Chronic. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change From Baseline in Sequential Response Time to Post-InterventionPrimary· Baseline and post-intervention
Aggregate time to complete movements between a six sequential targets presented on a computer touch screen in front of the participant. The mean of ten sequences was calculated prior to any practice and at a delayed retention test (e.g. no warm up or preceding practice) post-intervention. Change between the baseline average and post-intervention average was also calculated by subtracting post-intervention score from pre-intervention score. Positive numbers represent improvement in ability.
Time to Complete Sequence (Baseline)
Group
Value
95% CI
Active+Motor Practice
8.68
± 2.06
Sham+Motor Practice
8.84
± 1.47
Time to Complete Sequence (Delayed Retention)
Group
Value
95% CI
Active+Motor Practice
8.32
± 1.55
Sham+Motor Practice
7.96
± 1.04
Change in Time (Pre to Post)
Group
Value
95% CI
Active+Motor Practice
0.37
± 0.65
Sham+Motor Practice
0.88
± 0.63
Change From Baseline in Time to Complete the Jebsen-Taylor Hand Function TestSecondary· Baseline and post-intervention
The Jebsen-Taylor Hand Function Test is comprised of a series of unimanual tasks required for activities of daily living. Time to complete the Jebsen-Taylor Hand Function Test was assessed at baseline and post-intervention by taking the aggregate time to complete each activity. Change in time to complete the Jebsen-Taylor Hand Function Test between the baseline and post-intervention tests was derived by subtracting post-intervention score from baseline score. Positive scores indicate improvement in functional motor ability.
Pre Time to Complete (Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
95.68
± 51.71
Sham+Motor Practice
86.07
± 17.78
Post Time to Complete (Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
100.05
± 60.47
Sham+Motor Practice
76.27
± 20.97
Change Pre to Post (Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
-4.38
± 8.95
Sham+Motor Practice
9.80
± 6.14
Pre Time to Complete (Non-Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
55.75
± 11.22
Sham+Motor Practice
66.67
± 20.87
Post Time to Complete (Non-Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
51.97
± 8.25
Sham+Motor Practice
64.95
± 24.07
Change Pre to Post (Non-Stroke Affected Limb)
Group
Value
95% CI
Active+Motor Practice
3.78
± 5.33
Sham+Motor Practice
1.72
± 5.40
Change in Sequential Response Time Immediately Follow an Individual Bout of Non-invasive Brain Stimulation (e.g. Within Session)Secondary· Within session baseline to ~8 minutes post-application of non-invasive stimulation within the same session
Aggregate time to complete movements between a six sequential targets presented on a computer touch screen in front of the participant. The mean of ten sequences was calculated prior to application of Active+Motor Practice or Sham+Motor Practice for each intervention session and the first ten sequences of practice immediately following the specific form of non-invasive brain stimulation within each session. Change within a session was calculated by subtracting the post-stimulation score from the pre-stimulation score within a session. Positive values represent improved ability.
Session 1
Group
Value
95% CI
Active+Motor Practice
0.41
± 0.70
Sham+Motor Practice
0.89
± 0.36
Session 2
Group
Value
95% CI
Active+Motor Practice
0.72
± 1.97
Sham+Motor Practice
0.80
± 1.86
Session 3
Group
Value
95% CI
Active+Motor Practice
-0.20
± 0.60
Sham+Motor Practice
0.22
± 0.62
Session 4
Group
Value
95% CI
Active+Motor Practice
0.35
± 0.46
Sham+Motor Practice
0.23
± 0.39
Motor Evoked Potential Amplitude (in Microvolts) at Pre-baseline and Post-InterventionSecondary· Baseline and post-intervention
Motor evoked potential amplitude evoked by transcranial magnetic brain stimulation was recorded using electromyography over the first dorsal interosseous muscle of the stroke-affected hand. The means of ten trials at 120% (linear part of recruitment curve) and ten trials at 150% (recruitment curve plateau) of resting motor threshold were calculated and expressed in microvolts.
MEP Amplitude Pre (120% of RMT)
Group
Value
95% CI
Active+Motor Practice
1558
± 1020
Sham+Motor Practice
971
± 709
MEP Amplitude Post (120% of RMT)
Group
Value
95% CI
Active+Motor Practice
1216
± 1161
Sham+Motor Practice
511
± 279
MEP Amplitude Pre (150% of RMT)
Group
Value
95% CI
Active+Motor Practice
2750
± 2172
Sham+Motor Practice
1977
± 218
MEP Amplitude Post (150% of RMT)
Group
Value
95% CI
Active+Motor Practice
2008
± 2062
Sham+Motor Practice
2495
± 609
Change From Baseline in Cortical Excitability Post-InterventionSecondary· Baseline and post-intervention
Motor evoked potential amplitude evoked by transcranial magnetic brain stimulation was recorded using electromyography over the first dorsal interosseous muscle of the stroke-affected hand. The means of ten trials at 120% (linear part of recruitment curve) and ten trials at 150% (recruitment curve plateau) of resting motor threshold were calculated and expressed in microvolts. Change in motor evoked potential amplitude elicited by transcranial magnetic stimulation intensities of 120% (linear part of recruitment curve) and ten trials at 150% (recruitment curve plateau) of resting motor threshol
% change in MEP (120% RMT)
Group
Value
95% CI
Active+Motor Practice
-26
± 35
Sham+Motor Practice
-19
± 58
% change in MEP (150% RMT)
Group
Value
95% CI
Active+Motor Practice
-17
± 37
Sham+Motor Practice
25
± 17
Sponsor's own description
This study uses a form on non-invasive brain stimulation called transcranial magnetic stimulation to understand 1) understand how the brain learns post-stroke and 2) assess non-invasive brain stimulation as an addition to current stroke rehabilitation approaches. In two study arms the investigators will compare the effect of active transcranial magnetic stimulation paired with motor practice with placebo (or sham) transcranial magnetic stimulation paired with the same motor practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
· recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
· NA
· recruiting
NCT07356011 — Exoskeleton for Balance
· NA
· recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in
· NA
· recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
· NA
· recruiting
Other University of Michigan trials
Trials by the same sponsor.
NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation
· NA
· not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
· NA
· not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness
· NA
· not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health
· NA
· not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 27 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03086551.